Coya Therapeutics Inc (NAS:COYA)
$ 7.25 -0.08 (-1.09%) Market Cap: 121.13 Mil Enterprise Value: 138.29 Mil PE Ratio: 0 PB Ratio: 3.45 GF Score: 20/100

Coya Therapeutics Inc at LD Micro Invitational Conference Transcript

Jun 06, 2023 - Jun 07, 2023 / NTS GMT
Release Date Price: $4.34 (+3.33%)
Unidentified Participant

All right. We will begin our next presentation. Please welcome to the stage from Coya Therapeutics, Howard Berman.

Howard Berman
Coya Therapeutics, Inc. - CEO and Chairman of the Board

Great. It's a pleasure to be here today to present Coya Therapeutics. Forward-looking statements.

I just want to go over one of the key aspects of what we're doing and what happens to neurons when they get into trouble. As you see here on the slide, when neurons in different parts of the brain for Alzheimer's sits in the pyramidal neurons in the hippocampal regions, ALS or motor neurons, for instance, when they get into trouble, and there's inflammation that is a result, the immune system comes to try and remove some of the damage. And initially, it's helpful. But ultimately, it becomes a pathologic process resulting in the neurons actually undergoing death, cell death, and the neurons eventually end up dying.

And one of the critical components, as I mentioned, is the immune system. And the important thing to realize here is that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot